Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • You have access
    Preconditioning paradigms and pathways in the brain
    Karl B. Shpargel, Walid Jalabi, PhD, Yongming Jin, Alisher Dadabayev, MD, Marc S. Penn, MD, PhD and Bruce D. Trapp, PhD
    Cleveland Clinic Journal of Medicine March 2008, 75 (3 suppl 2) S77-S82;
  • You have access
    Should all patients with chronic kidney disease take a statin?
    Dena Rifkin, MD and Mark Sarnak, MD, MS
    Cleveland Clinic Journal of Medicine February 2008, 75 (2) 118-120;

    Some patients should take a statin, particularly those not yet on dialysis who have low-density lipoprotein cholesterol levels higher than 100 mg/dL. However, relatively few studies have addressed this question.

  • You have access
    Gadolinium and nephrogenic systemic fibrosis: The evidence of things not seen
    Jonathan Kay, MD
    Cleveland Clinic Journal of Medicine February 2008, 75 (2) 112-117;

    Much has been learned, but "nephrogenic" is misleading: this fibrosing disorder is not caused by the kidneys.

  • You have access
    Nephrogenic systemic fibrosis and its association with gadolinium exposure during MRI
    Naim Issa, MD, Emilio D. Poggio, MD, Richard A. Fatica, MD, Rajiv Patel, MD, Paul M. Ruggieri, MD and Robert J. Heyka, MD
    Cleveland Clinic Journal of Medicine February 2008, 75 (2) 95-111;

    This debilitating disorder can lead to serious complications and death. In patients with renal dysfunction, we should use gadolinium-based imaging studies with caution.

  • A young man with acute weakness of his right arm
    You have access
    A young man with acute weakness of his right arm
    Matthew A. Kaminski, MD, Carmela D. Tan, MD and Arman T. Askari, MD
    Cleveland Clinic Journal of Medicine February 2008, 75 (2) 145-152;

    A previously healthy, relatively young man has had a stroke. What is the cause and what should be done?

  • You have access
    Surprisingly nonbenign imaging
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine February 2008, 75 (2) 88;

    Nephrogenic systemic fibrosis is making us revise our view that “MRI with contrast” is a benign test.

  • You have access
    Screen for portopulmonary hypertension, especially in liver transplant candidates
    Karen L. Swanson, DO and Michael J. Krowka, MD
    Cleveland Clinic Journal of Medicine February 2008, 75 (2) 121-136;

    Portopulmonary hypertension should be looked for in patients with liver disease, especially if liver transplantation is being considered, as it may make transplantation riskier to perform.

  • You have access
    Infective endocarditis prophylaxis before dental procedures: New guidelines spark controversy
    Alice Kim, MD and Thomas Keys, MD
    Cleveland Clinic Journal of Medicine February 2008, 75 (2) 89-92;

    Many fewer people will need to receive antibiotics, according to new guidelines released by the American Heart Association.

  • You have access
    Red eye for the internist: When to treat, when to refer
    Anat Galor, MD and Bennie H. Jeng, MD
    Cleveland Clinic Journal of Medicine February 2008, 75 (2) 137-144;

    We review the conditions that can cause this ocular sign—the ones that internists can comfortably manage, and the ones that are best managed by an eye specialist.

  • You have access
    Preventing and managing diabetic complications in elderly patients
    Thomas Hornick, MD and David C. Aron, MD, MS
    Cleveland Clinic Journal of Medicine February 2008, 75 (2) 153-158;

    Elderly patients with diabetes are prone to a number of complications, some of which take precedence over, hinder, or preclude the intensive glucose control recommended for younger diabetic patients.

Pages

  • Previous
  • Next
  • 1
  • …
  • 279
  • 280
  • 281
  • 282
  • 283
  • 284
  • 285
  • 286
  • 287
  • …
  • 798

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire